Elixinol Wellness Limited Logo

Elixinol Wellness Limited

ELLXF

(1.8)
Stock Price

0,01 USD

-107.9% ROA

-98.83% ROE

-0.31x PER

Market Cap.

5.094.892,86 USD

15.7% DER

0% Yield

-59.27% NPM

Elixinol Wellness Limited Stock Analysis

Elixinol Wellness Limited Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Elixinol Wellness Limited Fundamental Stock Analysis
# Analysis Rating
1 PBV

With a remarkably low PBV ratio (0.38x), the stock offers substantial upside potential at a bargain price.

2 DER

The stock has a minimal amount of debt (21%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

3 Revenue Growth

This company's revenue has shown remarkable growth over the past three years, making it an excellent choice for seeking a consistently prosperous investment.

4 Net Profit Growth

This company's net profit has been consistently on the rise over the past three years, indicating a strong financial performance and making it an appealing investment opportunity.

5 Graham Number

The Graham number analysis indicates that this company's stock price is likely undervalued, raising prospects for a favorable investment opportunity.

6 ROE

Negative ROE (-74.88%) indicates poor financial performance, raising concerns about profitability and efficiency in utilizing shareholders' equity.

7 ROA

The stock's ROA (-79.28%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

8 Assets Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

9 Dividend Growth

Potential investors should be aware that the company's dividend growth has shown no upward trend in the past three years, indicating limited potential for increased returns.

10 Dividend

The company's decision to withhold dividends for three years raises questions about its ability to generate consistent returns.

11 Buffet Intrinsic Value

The company's stock presents a potential concern as it appears overvalued (0) by Warren Buffett's formula, indicating that its market price exceeds its estimated intrinsic value.

Elixinol Wellness Limited Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Elixinol Wellness Limited Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Sell
3 RSI Hold
4 Stoch RSI Sell

Elixinol Wellness Limited Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Elixinol Wellness Limited Revenue
Year Revenue Growth
2017 0
2018 37.131.000 100%
2019 27.183.000 -36.6%
2020 15.010.000 -81.1%
2021 9.338.000 -60.74%
2022 7.055.000 -32.36%
2023 8.269.000 14.68%
2024 27.088.000 69.47%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Elixinol Wellness Limited Research and Development Expenses
Year Research and Development Expenses Growth
2017 0
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Elixinol Wellness Limited General and Administrative Expenses
Year General and Administrative Expenses Growth
2017 6.354.000
2018 10.762.000 40.96%
2019 19.730.000 45.45%
2020 17.540.000 -12.49%
2021 12.954.000 -35.4%
2022 8.077.000 -60.38%
2023 6.167.000 -30.97%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Elixinol Wellness Limited EBITDA
Year EBITDA Growth
2017 -2.718.000
2018 -150.000 -1712%
2019 -22.291.000 99.33%
2020 52.334.000 142.59%
2021 -10.178.000 614.19%
2022 -8.291.000 -22.76%
2023 -5.836.000 -42.07%
2024 -7.860.000 25.75%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Elixinol Wellness Limited Gross Profit
Year Gross Profit Growth
2017 -17.000
2018 19.956.000 100.09%
2019 15.619.000 -27.77%
2020 6.666.000 -134.31%
2021 4.896.000 -36.15%
2022 3.238.000 -51.2%
2023 -1.804.000 279.49%
2024 -444.000 -306.31%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Elixinol Wellness Limited Net Profit
Year Net Profit Growth
2017 -2.711.000
2018 -860.000 -215.23%
2019 -83.343.000 98.97%
2020 -104.506.000 20.25%
2021 -17.025.000 -513.84%
2022 -10.571.000 -61.05%
2023 -7.507.000 -40.82%
2024 -11.024.000 31.9%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Elixinol Wellness Limited Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2017 0
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Elixinol Wellness Limited Free Cashflow
Year Free Cashflow Growth
2017 -658.000
2018 -10.254.000 93.58%
2019 -62.212.000 83.52%
2020 -22.949.000 -171.09%
2021 -14.363.000 -59.78%
2022 -8.164.000 -75.93%
2023 -2.775.000 -194.2%
2024 -2.190.000 -26.71%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Elixinol Wellness Limited Operating Cashflow
Year Operating Cashflow Growth
2017 -649.000
2018 -5.765.000 88.74%
2019 -51.066.000 88.71%
2020 -22.621.000 -125.75%
2021 -14.071.000 -60.76%
2022 -8.152.000 -72.61%
2023 -2.758.000 -195.58%
2024 -2.145.000 -28.58%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Elixinol Wellness Limited Capital Expenditure
Year Capital Expenditure Growth
2017 9.000
2018 4.489.000 99.8%
2019 11.146.000 59.73%
2020 328.000 -3298.17%
2021 292.000 -12.33%
2022 12.000 -2333.33%
2023 17.000 29.41%
2024 45.000 62.22%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Elixinol Wellness Limited Equity
Year Equity Growth
2017 99.416.000
2018 143.735.000 30.83%
2019 111.382.000 -29.05%
2020 35.651.000 -212.42%
2021 19.077.000 -86.88%
2022 9.158.000 -108.31%
2023 6.462.000 -41.72%
2024 7.434.000 13.08%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Elixinol Wellness Limited Assets
Year Assets Growth
2017 103.805.000
2018 153.694.000 32.46%
2019 121.069.000 -26.95%
2020 42.470.000 -185.07%
2021 25.332.000 -67.65%
2022 13.485.000 -87.85%
2023 11.711.000 -15.15%
2024 12.235.000 4.28%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Elixinol Wellness Limited Liabilities
Year Liabilities Growth
2017 4.388.000
2018 9.959.000 55.94%
2019 9.687.000 -2.81%
2020 6.819.000 -42.06%
2021 6.255.000 -9.02%
2022 4.327.000 -44.56%
2023 5.249.000 17.57%
2024 4.801.000 -9.33%

Elixinol Wellness Limited Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.02
Net Income per Share
-0.01
Price to Earning Ratio
-0.31x
Price To Sales Ratio
0.29x
POCF Ratio
-0.64
PFCF Ratio
-0.84
Price to Book Ratio
0.52
EV to Sales
0.27
EV Over EBITDA
-0.51
EV to Operating CashFlow
-0.79
EV to FreeCashFlow
-0.78
Earnings Yield
-3.2
FreeCashFlow Yield
-1.19
Market Cap
0,01 Bil.
Enterprise Value
0,00 Bil.
Graham Number
0.05
Graham NetNet
0

Income Statement Metrics

Net Income per Share
-0.01
Income Quality
0.49
ROE
-1.72
Return On Assets
-0.56
Return On Capital Employed
-0.63
Net Income per EBT
1
EBT Per Ebit
1.41
Ebit per Revenue
-0.42
Effective Tax Rate
-0

Margins

Sales, General, & Administrative to Revenue
0.12
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0.03
Gross Profit Margin
0.15
Operating Profit Margin
-0.42
Pretax Profit Margin
-0.59
Net Profit Margin
-0.59

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.01
Free CashFlow per Share
-0.01
Capex to Operating CashFlow
-0.01
Capex to Revenue
0
Capex to Depreciation
0.05
Return on Invested Capital
-1.2
Return on Tangible Assets
-1.08
Days Sales Outstanding
42.17
Days Payables Outstanding
41
Days of Inventory on Hand
80.18
Receivables Turnover
8.65
Payables Turnover
8.9
Inventory Turnover
4.55
Capex per Share
0

Balance Sheet

Cash per Share
0,00
Book Value per Share
0,01
Tangible Book Value per Share
0.01
Shareholders Equity per Share
0.01
Interest Debt per Share
0
Debt to Equity
0.16
Debt to Assets
0.1
Net Debt to EBITDA
0.04
Current Ratio
1.81
Tangible Asset Value
0,01 Bil.
Net Current Asset Value
0,00 Bil.
Invested Capital
6000000
Working Capital
0,00 Bil.
Intangibles to Total Assets
0.07
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
3864500
Debt to Market Cap
0.23

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Elixinol Wellness Limited Dividends
Year Dividends Growth

Elixinol Wellness Limited Profile

About Elixinol Wellness Limited

Elixinol Wellness Limited, through its subsidiaries, manufactures and distributes hemp derived nutraceuticals, cosmetics, and food products under the Elixinol and Hemp Foods Australia brands in the Americas, Europe, and Australia. It offers hemp derived cannabidiol and food products, dietary supplements, topicals, and skincare products. The company was formerly known as Elixinol Global Limited and changed its name to Elixinol Wellness Limited in May 2021. The company was incorporated in 2017 and is headquartered in Sydney, Australia.

CEO
Ms. Josephine Mary Lorenz
Employee
0
Address
680 George Street
Sydney, 2000

Elixinol Wellness Limited Executives & BODs

Elixinol Wellness Limited Executives & BODs
# Name Age
1 Glen Zurcher
Account Director of Investor Relations Department
70
2 Ms. Melanie Leydin
Company Secretary
70
3 Ms. Natalie Butler
Head of Marketing & Executive Director
70
4 Ms. Josephine Mary Lorenz
Group Chief Financial Officer
70

Elixinol Wellness Limited Competitors